• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Kikuchi Ken  菊地 顕

… Alternative Names

KIKUCHI ken  菊地 顕

KIKUCHI Ken  菊地 顕

Less
Researcher Number 40453104
Other IDs
  • ORCIDhttps://orcid.org/0000-0003-3097-7480
Affiliation (Current) 2025: 京都府立医科大学, 医学(系)研究科(研究院), 特任講師
Affiliation (based on the past Project Information) *help 2021 – 2024: 京都府立医科大学, 医学(系)研究科(研究院), 特任講師
2016 – 2020: 京都府立医科大学, 医学(系)研究科(研究院), 特任助教
2013 – 2015: 京都府立医科大学, 医学(系)研究科(研究院), 助教
2008 – 2010: Kyoto Prefectural University of Medicine, 医学研究科, 助教
Review Section/Research Field
Principal Investigator
Pediatrics / Basic Section 52050:Embryonic medicine and pediatrics-related
Except Principal Investigator
Basic Section 52050:Embryonic medicine and pediatrics-related / Pediatrics / Basic Section 50020:Tumor diagnostics and therapeutics-related / Tumor therapeutics / Pediatric surgery
Keywords
Principal Investigator
横紋筋肉腫 / PAX3-FOXO1 / Myostatin / 患者腫瘍組織移植モデル / 鶏卵漿尿膜法 / 小児がん / 鶏卵漿尿膜 / CAMアッセイ / プレシジョン医療 / RAS … More / MEK阻害剤 / RAS変異 / RAF-MEK阻害剤 / チェックポイントアダプテーション / PAX3-FOXO1A / 胞巣型横紋筋肉腫 / 血清DNA / H19 / 血清遊離DNA / IGF2 / インプリンティング … More
Except Principal Investigator
横紋筋肉腫 / 小児がん / 神経芽腫 / 融合遺伝子 / 腫瘍溶解性アデノウイルス / 遺伝子改変T細胞 / 免疫疲弊 / CAR-T細胞 / 腫瘍溶解性ウイルス / CAR-T / エクソソーム / ヒギーバックトランスポゾン / 小児腫瘍 / PD-L1 / 免疫療法 / 腫瘍マーカー / microRNA / 小児固形腫瘍 / WT1 / 間葉系間質細胞 / メタボロミクス解析 / 脂質代謝制御 / FOXO1 / PLAGL1 / miRNA / 分化 / T-reg / 制御性T細胞 / エフェクターサイトカイン / プロモーター制御 / CAR-T療法 / CAR-T細胞療法 / 遺伝子改変アデノウイルスベクター / CD19 / オフターゲット / 腫瘍微小環境 / 固形腫瘍 / 細胞療法 / キメラ抗原受容体T細胞 / ピギーバックトランスポゾン / EPHB4 / ドラッグデリバリー / 間葉系幹細胞 / siRNA / INI1 / 新規治療 / SMARCB1 / 癌幹細胞 / がん幹細胞 / CD44 / survivin / FOXM1 / 幹細胞 / ラブドイド腫瘍 / アポトーシス / HDAC阻害剤 / チェックポイント阻害剤 / 抗PD-1抗体 / B7-H3 / PAX3-FOXO1 / 髄液 / 血清 / liquid biopsy / PD-1 / 免疫チェックポイント / 再発 / スーパーハイリスク / ハイリスク / スーパーハイリスク / 融合遺云子 / PAX3-FKHR / miR-206 / 血清診断 / 分子標的療法 Less
  • Research Projects

    (22 results)
  • Research Products

    (33 results)
  • Co-Researchers

    (13 People)
  •  The development of novel treatment startegies for rhabdomyosarcoma based on lipid metabolism regulation

    • Principal Investigator
      土屋 邦彦
    • Project Period (FY)
      2024 – 2026
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 52050:Embryonic medicine and pediatrics-related
    • Research Institution
      Kyoto Prefectural University of Medicine
  •  Development of gene cell therapy using mesenchymal stromal cells for neuroblastoma

    • Principal Investigator
      家原 知子
    • Project Period (FY)
      2023 – 2025
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 52050:Embryonic medicine and pediatrics-related
    • Research Institution
      Kyoto Prefectural University of Medicine
  •  Development of novel gene therapy for rhabdomyosarcomaPrincipal Investigator

    • Principal Investigator
      菊地 顕
    • Project Period (FY)
      2023 – 2025
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 52050:Embryonic medicine and pediatrics-related
    • Research Institution
      Kyoto Prefectural University of Medicine
  •  Novel therapeutic strategy for pediatric malignant solid tumors using WT1 promoter-regulated oncovirus

    • Principal Investigator
      吉田 秀樹
    • Project Period (FY)
      2023 – 2025
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 52050:Embryonic medicine and pediatrics-related
    • Research Institution
      Kyoto Prefectural University of Medicine
  •  Characterization of PLAGL1-FOXO1 fusion gene in alveolar rhabdomyosarcoma

    • Principal Investigator
      宮地 充
    • Project Period (FY)
      2022 – 2024
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 52050:Embryonic medicine and pediatrics-related
    • Research Institution
      Kyoto Prefectural University of Medicine
  •  Development of combinatorial CAR-T cell therapy improving immunosupressive tumor microenvironment

    • Principal Investigator
      Yagyu Shigeki
    • Project Period (FY)
      2020 – 2022
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Kyoto Prefectural University of Medicine
  •  Gene and cell therapy combining CD19-expressing adenovirus and CD19 CAR-T cells

    • Principal Investigator
      Yoshida Hideki
    • Project Period (FY)
      2020 – 2022
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Kyoto Prefectural University of Medicine
  •  In ovo chorioallantoic membrane assay as a xenograft model for pediatric rhabdomyosarcomaPrincipal Investigator

    • Principal Investigator
      Kikuchi Ken
    • Project Period (FY)
      2020 – 2022
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 52050:Embryonic medicine and pediatrics-related
    • Research Institution
      Kyoto Prefectural University of Medicine
  •  Development of CAR-T cell therapy complementary system for rhabdomyosarcoma using oncolytic virus

    • Principal Investigator
      Hosoi Hajime
    • Project Period (FY)
      2020 – 2022
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Kyoto Prefectural University of Medicine
  •  Examination of novel prognostic markers related to spontaneous regression and differentiation of neuroblastoma

    • Principal Investigator
      Iehara Tomoko
    • Project Period (FY)
      2020 – 2022
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 52050:Embryonic medicine and pediatrics-related
    • Research Institution
      Kyoto Prefectural University of Medicine
  •  Identifying and analyzing biological characteristics of rhabdoid tumor stem cells to establish new treatment

    • Principal Investigator
      Katsumi Yoshiki
    • Project Period (FY)
      2018 – 2020
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 52050:Embryonic medicine and pediatrics-related
    • Research Institution
      Kyoto Prefectural University of Medicine
  •  Study of specific gene expression in intractable childhood cancer and growth suppression and differentiation inducing effect of HDAC inhibitors

    • Principal Investigator
      Iehara Tomoko
    • Project Period (FY)
      2017 – 2019
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Pediatrics
    • Research Institution
      Kyoto Prefectural University of Medicine
  •  Mutations in the RAS Pathway as Potential Precision Medicine Targets in Treatment of RhabdomyosarcomaPrincipal Investigator

    • Principal Investigator
      Kikuchi Ken
    • Project Period (FY)
      2017 – 2019
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Pediatrics
    • Research Institution
      Kyoto Prefectural University of Medicine
  •  A novel cell and gene therapy for human rhabdomyosarcoma using exosome delivery system

    • Principal Investigator
      Hosoi Hajime
    • Project Period (FY)
      2017 – 2019
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Pediatrics
    • Research Institution
      Kyoto Prefectural University of Medicine
  •  Development of chimeric antigen receptor T cells redirecting a growth factor receptor on human rhabdomyosarcoma

    • Principal Investigator
      Yagyu Shigeki
    • Project Period (FY)
      2017 – 2019
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Tumor therapeutics
    • Research Institution
      Kyoto Prefectural University of Medicine
  •  Development of new treatment strategy for rhabdomyosarcoma using serum and cerebrospinal fluid microRNA

    • Principal Investigator
      Miyachi Mitsuru
    • Project Period (FY)
      2016 – 2018
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Pediatrics
    • Research Institution
      Kyoto Prefectural University of Medicine
  •  Elucidation of tumor immunity mechanism for clinical application of anti-PD1 antibody in childhood cancer

    • Principal Investigator
      Tsuchiya Kunihiko
    • Project Period (FY)
      2016 – 2018
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Pediatrics
    • Research Institution
      Kyoto Prefectural University of Medicine
  •  Study of recurrence mechanism in super high-risk neuroblastoma

    • Principal Investigator
      Tomoko Iehara
    • Project Period (FY)
      2014 – 2016
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Pediatrics
    • Research Institution
      Kyoto Prefectural University of Medicine
  •  The establishment of peptide vaccine as a consolidation therapy for childhood cancer.

    • Principal Investigator
      Hosoi Hajime
    • Project Period (FY)
      2014 – 2016
    • Research Category
      Grant-in-Aid for Challenging Exploratory Research
    • Research Field
      Pediatrics
    • Research Institution
      Kyoto Prefectural University of Medicine
  •  The investigation of cell-cycle dependent expression of PAX3-FOXO1A in Rhabdomyosarcoma.Principal Investigator

    • Principal Investigator
      KIKUCHI ken
    • Project Period (FY)
      2013 – 2014
    • Research Category
      Grant-in-Aid for Research Activity Start-up
    • Research Field
      Pediatrics
    • Research Institution
      Kyoto Prefectural University of Medicine
  •  The development of novel diagnostics and treatment for refractory rhabdomyosarcoma

    • Principal Investigator
      HOSOI Hajime
    • Project Period (FY)
      2010 – 2012
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Pediatric surgery
    • Research Institution
      Kyoto Prefectural University of Medicine
  •  Detection of imprinting abnormalities in rhabdomyosarcoma patients using tumor and serum DNA.Principal Investigator

    • Principal Investigator
      KIKUCHI Ken
    • Project Period (FY)
      2008 – 2010
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Pediatrics
    • Research Institution
      Kyoto Prefectural University of Medicine

All 2023 2022 2021 2019 2018 2017 2014 2009 2008 Other

All Journal Article Presentation

  • [Journal Article] <i>In?ovo</i> chorioallantoic membrane assay as a xenograft model for pediatric rhabdomyosarcoma2023

    • Author(s)
      Shoji Chika、Kikuchi Ken、Yoshida Hideki、Miyachi Mitsuru、Yagyu Shigeki、Tsuchiya Kunihiko、Nakaya Takaaki、Hosoi Hajime、Iehara Tomoko
    • Journal Title

      Oncology Reports

      Volume: 49 Issue: 4

    • DOI

      10.3892/or.2023.8513

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-20K08187
  • [Journal Article] The histone deacetylase inhibitor OBP‐801 has <i>in?vitro</i> / <i>in?vivo</i> anti‐neuroblastoma activity2022

    • Author(s)
      Kaneda Daisuke、Iehara Tomoko、Kikuchi Ken、Sugimoto Yohei、Nakagawa Norio、Yagyu Shigeki、Miyachi Mitsuru、Konishi Eiichi、Sakai Toshiyuki、Hosoi Hajime
    • Journal Title

      Pediatrics International

      Volume: 64 Issue: 1 Pages: 15159-15166

    • DOI

      10.1111/ped.15159

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20K08212
  • [Journal Article] Development of non-viral, ligand-dependent, EPHB4-specific chimeric antigen receptor T cells for treatment of rhabdomyosarcoma.2021

    • Author(s)
      Kubo H, Yagyu S, Nakamura K, Yamashima K, Tomida A, Kikuchi K, Iehara T, Nakazawa Y, Hosoi H.
    • Journal Title

      Molecular Therapy - Oncolytics

      Volume: 20 Pages: 646-658

    • DOI

      10.1016/j.omto.2021.03.001

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K08326, KAKENHI-PROJECT-20K07641
  • [Journal Article] Mutations in the RAS pathway as potential precision medicine targets in treatment of rhabdomyosarcoma.2019

    • Author(s)
      Nakagawa N, Kikuchi K, Yagyu S, Miyachi M, Iehara T, Tajiri T, Sakai T, Hosoi H.
    • Journal Title

      Biochem Biophys Res Commun

      Volume: 512 Issue: 3 Pages: 524-530

    • DOI

      10.1016/j.bbrc.2019.03.038

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K10123, KAKENHI-PROJECT-17H04230, KAKENHI-PROJECT-19K09053, KAKENHI-PLANNED-17H06398, KAKENHI-PROJECT-19H01079, KAKENHI-PROJECT-19H03719, KAKENHI-PROJECT-17K11517, KAKENHI-PROJECT-17K11518
  • [Journal Article] OBP;801, a novel histone deacetylase inhibitor, induces M;phase arrest and apoptosis in rhabdomyosarcoma cells.2019

    • Author(s)
      Tomoyasu C, Kikuchi K, Kaneda D, Yagyu S, Miyachi M, Tsuchiya K, Iehara T, Sakai T, Hosoi H
    • Journal Title

      Oncol Rep

      Volume: 41(1) Pages: 643-649

    • DOI

      10.3892/or.2018.6813

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-17K10122
  • [Journal Article] OBP-801, a novel histone deacetylase inhibitor, induces M phase arrest and apoptosis in rhabdomyosarcoma cells.2019

    • Author(s)
      Tomoyasu C, Kikuchi K, Kaneda D, Yagyu S, Miyachi M, Tsuchiya K, Iehara T, Sakai T, Hosoi H.
    • Journal Title

      Oncol Rep.

      Volume: 41 Pages: 643-649

    • DOI

      10.3892/or.2019.6997

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17H04230
  • [Journal Article] Cell-cycle dependent expression of a translocation-mediated fusion oncogene mediates checkpoint adaptation in rhabdomyosarcoma.2014

    • Author(s)
      Kikuchi K, Hettmer S, Aslam MI, Michalek JE, Laub W, Wilky BA, Loeb DM, Rubin BP, Wagers AJ, Keller C
    • Journal Title

      PLoS genetics.

      Volume: e1004107 Issue: 1 Pages: e1004107-e1004107

    • DOI

      10.1371/journal.pgen.1004107

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-25893202
  • [Journal Article] Restoration of p53 pathway by nutlin-3 induces cell cycle arrest and apoptosis in human rhabdomyosarcoma cells.2009

    • Author(s)
      Miyachi M, Kakazu N, Yagyu S, Katsumi Y, Tsubai-Shimizu S, Kikuchi K, Tsuchiya K, Iehara T, Hosoi H.
    • Journal Title

      Clinical cancer research. 15

      Pages: 4077-4084

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20790738
  • [Journal Article] Restoration of p53 pathway by nutlin-3 induces cell cycle arrest and apoptosis in human rhabdomyosarcoma cells.2009

    • Author(s)
      Miyachi M, Kakazu N, Yagyu S, Katsumi Y, Tsubai-Shimizu S, Kikuchi K, Tsuchiya K, Iehara T, Hosoi H.
    • Journal Title

      Clinical cancer research 15

      Pages: 4077-4084

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20790738
  • [Presentation] Identification of the PLAGL1-FOXO1 fusion gene in a case of alveolar rhabdomyosarcoma.2022

    • Author(s)
      Sugitatsu Y,Oya S,Kondo H,Tomida A, Yoshida H,Miyachi M,Kikuchi K, Tsuchiya K, Iehara T
    • Organizer
      第64回日本小児血液・がん学会学術集会
    • Data Source
      KAKENHI-PROJECT-22K07940
  • [Presentation] Development of chimeric antigen receptor T cell therapy for human rhabdomypsarcoma.2019

    • Author(s)
      Yagyu S, Morita D, Tanaka M, Kikuchi K, Iehara T, Nakazawa Y, Hosoi H
    • Organizer
      The 2nd International Cancer Research Symposium of Training Plan for Oncology Professionals.
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17H04230
  • [Presentation] Development of PiggyBac Transposon Mediated CAR-T Cells Targeting EPHB4 for Pediatric Solid Tumors.2019

    • Author(s)
      Yagyu S, Tomida A, Kubo H, Yamashima K, Kikuchi K, Nakamura K, Tanaka M, Nakazawa Y, Iehara T, Hosoi H.
    • Organizer
      51st Annual Congress of the International Society of Paediatric Oncology
    • Data Source
      KAKENHI-PROJECT-17H04230
  • [Presentation] Development of PiggyBac Transposon Mediated CAR-T Cells Targeting EPHB4 for Pediatric Solid Tumors.2019

    • Author(s)
      Yagyu S, Tomida A, Kubo H, Yamashima K, Kikuchi K, Nakamura K, Tanaka M, Nakazawa Y, Iehara T, Hosoi H.
    • Organizer
      51st Annual Congress of the International Society of Paediatric Oncology
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K07224
  • [Presentation] 横紋筋肉腫に対する新たな治療戦略2018

    • Author(s)
      Kikuchi K, Hosoi H
    • Organizer
      第60回日本小児血液・がん学会学術集会
    • Data Source
      KAKENHI-PROJECT-17H04230
  • [Presentation] The novel histone deacetylase inhibitor OBP-801 induces apoptosis in neuroblastoma tumor cells2018

    • Author(s)
      Daisuke Kaneda, Ken Kikuchi, Kayoko Nakamura, Shigeki Yagyu, Tomoko Iehara, Toshiyuki Sakai, Hajime Hosoi
    • Organizer
      Advances in Neuroblastoma research
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K10122
  • [Presentation] 横紋筋肉腫に対する新規 RAF/MEK デュアル阻害剤の検討2018

    • Author(s)
      Nakagawa N, Kikuchi K, Yagyu S, Iehara T, Sakai T, Hosoi H.
    • Organizer
      第60回日本小児血液・がん学会学術集会
    • Data Source
      KAKENHI-PROJECT-17H04230
  • [Presentation] 横紋筋肉腫における新規ヒストン脱アセチル化酸素阻害剤OBP-801の抗腫瘍効果2018

    • Author(s)
      菊地顕,友安千紘,中村加世子,柳生茂希,宮地充,勝見良樹,土屋邦彦,家原知子,酒井敏行,細井 創
    • Organizer
      第121回日本小児科学会学術集会
    • Data Source
      KAKENHI-PROJECT-17K10122
  • [Presentation] 横紋筋肉腫における新規ヒストン脱アセチル化酸素阻害剤OBP-801の抗腫瘍効果.2018

    • Author(s)
      菊地顕,友安千紘,中村加世子,柳生茂希,宮地充,勝見良樹,土屋邦彦,家原知子,酒井敏行,細井 創
    • Organizer
      第121回日本小児科学会学術集会
    • Data Source
      KAKENHI-PROJECT-17H04230
  • [Presentation] The novel histone deacetylase inhibitor OBP-801 induces apoptosis in neuroblastoma tumor cells2018

    • Author(s)
      Daisuke Kaneda, Ken Kikuchi, Kayoko Nakamura, Shigeki Yagyu, Tomoko Iehara, Toshiyuki Sakai, Hajime Hosoi
    • Organizer
      Advances in NEうろbぁs苫Research
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K10122
  • [Presentation] 横紋筋肉腫における新規ヒストン脱メチル化酵素阻害剤の抗腫瘍効果と分子機構の解析2018

    • Author(s)
      菊地顕、友安千紘、中村加世子、柳生茂希、宮地充、家原知子、酒井敏行、細井創
    • Organizer
      第121回日本小児科学会学術集会
    • Data Source
      KAKENHI-PROJECT-17K10122
  • [Presentation] Novel allosteric RAF/MEK inhibitor in the treatment of rhabdomyosarooma.2018

    • Author(s)
      Nakagawa N, Kikuchi K, Yagyu S, Iehara T, Sakai T, Hosoi H.
    • Organizer
      第60回日本小児血液・がん学会学術集会
    • Data Source
      KAKENHI-PROJECT-17K10123
  • [Presentation] Chimeric Antigen Receptor T cells redirecting EPHB4 for the Treatment of Human Rhabdomyosarcoma.2017

    • Author(s)
      Yagyu S,Nakamura K,Morita D,Kikuchi K,Iehara T,Hosoi H,Nakazawa Y.
    • Organizer
      第23回日本遺伝子細胞治療学会学術集会
    • Data Source
      KAKENHI-PROJECT-17H04230
  • [Presentation] Chimeric Antigen Receptor T cells redirecting EPHB4 for the Treatment of Human Rhabdomyosarcoma.2017

    • Author(s)
      Yagyu S,Nakamura K,Morita D,Kikuchi K,Iehara T,Hosoi H,Nakazawa Y.
    • Organizer
      第59回日本小児血液がん学会学術集会
    • Data Source
      KAKENHI-PROJECT-17H04230
  • [Presentation] Chimeric Antigen Receptor T cells redirecting EPHB4 for the Treatment of Human Rhabdomyosarcoma.2017

    • Author(s)
      Nakamura K,Yagyu S,Morita D,Kikuchi K,Iehara T,Hosoi H,Nakazawa Y.
    • Organizer
      第2回日本遺伝子細胞治療学会若手研究会
    • Data Source
      KAKENHI-PROJECT-17K07224
  • [Presentation] Chimeric Antigen Receptor T cells redirecting EPHB4 for the Treatment of Human Rhabdomyosarcoma.2017

    • Author(s)
      Yagyu S,Nakamura K,Morita D,Kikuchi K,Iehara T,Hosoi H,Nakazawa Y.
    • Organizer
      第23回日本遺伝子細胞治療学会学術集会
    • Data Source
      KAKENHI-PROJECT-17K07224
  • [Presentation] Mutation of Ras Pathway Should be a Target of Precision Medicine for Rhabdomyosarcoma2017

    • Author(s)
      N. nakagawa, K. Kikuchi, K. Nakamura, T. Tanaka, S. Yagyu, T. Iehara, T. Tajiri, T. Sakai, H. Hosoi
    • Organizer
      49th CONGRESS OF THE INTERNATIONAL SOCIETY OF PAEDIATRIC ONCOLOGY (SIOP)
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K10123
  • [Presentation] Chimeric Antigen Receptor T cells redirecting EPHB4 for the Treatment of Human Rhabdomyosarcoma2017

    • Author(s)
      Yagyu S,Nakamura K,Morita D,Kikuchi K,Iehara T,Hosoi H,Nakazawa Y.
    • Organizer
      第59回日本小児血液が学会学術集会
    • Data Source
      KAKENHI-PROJECT-17K07224
  • [Presentation] Chimeric Antigen Receptor T cells redirecting EPHB4 for the Treatment of Human Rhabdomyosarcoma.2017

    • Author(s)
      Nakamura K,Yagyu S,Morita D,Kikuchi K,Iehara T,Hosoi H,Nakazawa Y.
    • Organizer
      第2回日本遺伝子細胞治療学会若手研究会
    • Data Source
      KAKENHI-PROJECT-17H04230
  • [Presentation] 横紋筋肉腫患者血清遊離DNAを用いたIGF2/H19 imprinting異常の検出2008

    • Author(s)
      菊地顕
    • Organizer
      第111回日本小児科学会学術集会
    • Place of Presentation
      東京
    • Year and Date
      2008-04-26
    • Data Source
      KAKENHI-PROJECT-20790738
  • [Presentation] Detection of IGF2 and H19 imprinting abnormalities in rhabdomyosarcoma patients using tumor and serum DNA.2008

    • Author(s)
      Kikuchi K.
    • Organizer
      40th International Society of Pediatric Oncology.
    • Place of Presentation
      Berlin, Germany
    • Data Source
      KAKENHI-PROJECT-20790738
  • [Presentation] Detection of IGF2 and H19 imprinting abnormalities in rhabdomyosarcoma patients using tumor and serum DNA.2008

    • Author(s)
      Ken Kikuchi
    • Organizer
      40th International Society of Pediatric Oncology
    • Place of Presentation
      Berlin, Germany
    • Data Source
      KAKENHI-PROJECT-20790738
  • [Presentation] Effects of PAX3-FOXO1 in alveolar rhabdomyosarcoma.

    • Author(s)
      菊地 顕、Simone Hettmer、Amy J. Wagers、Brian P. Rubin、Charles Keller、細井 創
    • Organizer
      第118回日本小児科学会学術集会
    • Place of Presentation
      大阪
    • Year and Date
      2015-04-17 – 2015-04-19
    • Data Source
      KAKENHI-PROJECT-25893202
  • [Presentation] Cell-Cycle Dependent Expression of a Translocation-Mediated Fusion Oncogene Mediates Checkpoint Adaptation in Rhabdomyosarcoma

    • Author(s)
      Ken Kikuchi, Simone Hettmer, M. Imran Aslam, Joel E. Michalek, Wolfram Laub, Breelyn A. Wilky, David M. Loeb, Brian P. Rubin, Amy J. Wagers, Charles Keller, Hosoi Hajime
    • Organizer
      第56回日本小児血液・がん学会学術集会
    • Place of Presentation
      福岡
    • Year and Date
      2014-11-28 – 2014-11-30
    • Data Source
      KAKENHI-PROJECT-25893202
  • 1.  IEHARA Tomoko (20285266)
    # of Collaborated Projects: 15 results
    # of Collaborated Products: 20 results
  • 2.  Miyachi Mitsuru (40584983)
    # of Collaborated Projects: 13 results
    # of Collaborated Products: 8 results
  • 3.  Yagyu Shigeki (10572547)
    # of Collaborated Projects: 13 results
    # of Collaborated Products: 23 results
  • 4.  HOSOI Hajime (20238744)
    # of Collaborated Projects: 10 results
    # of Collaborated Products: 18 results
  • 5.  Yoshida Hideki (10643546)
    # of Collaborated Projects: 9 results
    # of Collaborated Products: 2 results
  • 6.  TSUCHIYA Kunihiko (90381938)
    # of Collaborated Projects: 6 results
    # of Collaborated Products: 1 results
  • 7.  桑原 康通 (30590327)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 0 results
  • 8.  Katsumi Yoshiki (00808496)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 9.  小野 滋 (00315962)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 10.  中沢 洋三 (60397312)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 4 results
  • 11.  中屋 隆明 (80271633)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 12.  松尾 雅文 (10157266)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 13.  富田 晃正 (30933022)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results

URL: 

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi